P. Vollenweider et al., IMPAIRED INSULIN-INDUCED SYMPATHETIC NEURAL ACTIVATION AND VASODILATION IN SKELETAL-MUSCLE IN OBESE HUMANS, The Journal of clinical investigation, 93(6), 1994, pp. 2365-2371
The sympathetic nervous system is an important regulatory mechanism of
both metabolic and cardiovascular function, and altered sympathetic a
ctivity may play a role in the etiology and/or complications of obesit
y. In lean subjects, insulin evokes sympathetic activation and vasodil
ation in skeletal muscle. In obese subjects such vasodilation is impai
red and, in turn, may contribute to insulin resistance. To examine the
relationship between sympathetic and vasodilatory responses in skelet
al muscle to hyperinsulinemia, we simultaneously measured muscle sympa
thetic nerve activity (MSNA) and calf blood flow at basal and during a
2-h hyperinsulinemic (6 pmol/kg per min) euglycemic clamp in eight le
an and eight obese subjects. The major findings of this study are twof
old: obese subjects had a 2.2 times higher fasting rate of MSNA, and e
uglycemic hyperinsulinemia, which more than doubled MSNA and increased
calf blood flow by roughly 30% in lean subjects, had only a minor vas
odilatory and sympathoexcitatory effect in obese subjects. In contrast
, two non-insulin-sympathetic stimuli evoked comparably large increase
s in MSNA in lean and obese subjects. We conclude that insulin resista
nce in obese subjects is associated with increased fasting MSNA and a
specific impairment of sympathetic neural responsiveness to physiologi
cal hyperinsulinemia in skeletal muscle tissue.